Limited Submission Opportunities – Open Calls
Institutionally Coordinated Submissions
Welcome to the current listing of open limited submission opportunities available through the ORSD. These opportunities represent competitive funding programs in which the sponsor limits the number of applications an institution may submit. To ensure a fair and strategic selection process, ORSD coordinates internal reviews and nominations when necessary.
Each listing includes key details such as eligibility criteria, internal deadlines, sponsor deadlines, and links to full program guidelines. Faculty and researchers are encouraged to review these opportunities regularly and begin preparing proposals early.
If you are aware of a limited submission opportunity that is not listed, please email the RDTE%20Information%20Specialist to ensure it is reviewed and appropriately coordinated.
Open Calls
No open calls at this time.
Upcoming Opportunities
Rare Disease Endpoint Advancement (RDEA) Pilot Program
FDA-2022-N-2480
Sponsor: U. S. Department of Agriculture – Food & Drug Administration
The RDEA Pilot Program is a joint program of the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research. The program is designed to:
- Seek to advance rare disease drug development programs …
- Promote innovation and evolving science by sharing learnings …
- Develop FDA staff capacity to enable and facilitate the development and use of novel
endpoints
IC: January 12, 2026 - January 16, 2026
Notifications: Week of January 26, 2026
Sponsor Deadline: March 31, 2026
PAR-23-077 Collaborative Program Grant for Multidisciplinary Teams
(RM1 - Clinical Trial Optional)
Sponsor: U.S. Department of Health and Human Services – National Institutes of Health – National Institute for General Medical Sciences
The Collaborative Program Grant is designed to support research in which funding a team of interdependent investigators to achieve a unified scientific goal offers significant advantages over supporting individual research project grants.
IC: February 9, 2026 - February 13, 2026
Notifications: Week of February 23, 2026
Sponsor Deadline: May 27, 2026